Customer Publication

Edaravone Protects Against Methylglyoxal-induced Barrier Damage in Human Brain Endothelial Cells

Authors: A. Tóth et al.

Journal: PLOS ONE (2014)

Institution: Hungarian Academy of Sciences

Research Areas: Drug development

Cell Lines: hCMEC/D3 (Human brain endothelial cells)

Summary: Using holographic microscopy for label-free analysis of living cells, visualized for the first time the kinetics of morphological changes caused by methylglyoxal. The morphology data confirmed that edavarone completely prevented methylglyoxal-induced changes in morphology and detachment of cells.

Keywords: Holomonitor M3, cell morphology, mode of action. drug against brain damage after acute brain ischemia and infarction

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2